Free Trial
NASDAQ:ANNX

Annexon (ANNX) Stock Price, News & Analysis

Annexon logo
$2.56 -0.25 (-8.75%)
As of 03:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Annexon Stock (NASDAQ:ANNX)

Key Stats

Today's Range
$2.55
$2.74
50-Day Range
$1.61
$2.96
52-Week Range
$1.28
$7.85
Volume
1.14 million shs
Average Volume
1.61 million shs
Market Capitalization
$279.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.50
Consensus Rating
Buy

Company Overview

Annexon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

ANNX MarketRank™: 

Annexon scored higher than 55% of companies evaluated by MarketBeat, and ranked 602nd out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Annexon has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Annexon has only been the subject of 2 research reports in the past 90 days.

  • Read more about Annexon's stock forecast and price target.
  • Earnings Growth

    Earnings for Annexon are expected to decrease in the coming year, from ($0.96) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Annexon is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Annexon is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Annexon has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Annexon's valuation and earnings.
  • Percentage of Shares Shorted

    10.47% of the float of Annexon has been sold short.
  • Short Interest Ratio / Days to Cover

    Annexon has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Annexon has recently increased by 1.50%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Annexon does not currently pay a dividend.

  • Dividend Growth

    Annexon does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.47% of the float of Annexon has been sold short.
  • Short Interest Ratio / Days to Cover

    Annexon has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Annexon has recently increased by 1.50%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Annexon has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Annexon this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for ANNX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Annexon insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,123.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    11.87% of the stock of Annexon is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Annexon's insider trading history.
Receive ANNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Annexon and its competitors with MarketBeat's FREE daily newsletter.

ANNX Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

ANNX Stock Analysis - Frequently Asked Questions

Annexon's stock was trading at $5.13 at the beginning of 2025. Since then, ANNX shares have decreased by 48.8% and is now trading at $2.6250.

Annexon, Inc. (NASDAQ:ANNX) posted its quarterly earnings results on Monday, May, 12th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07.

Annexon (ANNX) raised $150 million in an initial public offering on Friday, July 24th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, BofA Securities and Cowen acted as the underwriters for the IPO.

Shares of ANNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Annexon investors own include NVIDIA (NVDA), MercadoLibre (MELI), Advanced Micro Devices (AMD), Meta Platforms (META), CRISPR Therapeutics (CRSP) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/12/2025
Today
7/11/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ANNX
CIK
1528115
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$14.00
Low Price Target
$11.00
Potential Upside/Downside
+346.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$138.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-54.45%
Return on Assets
-46.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.99
Quick Ratio
7.99

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.75 per share
Price / Book
1.02

Miscellaneous

Outstanding Shares
109,710,000
Free Float
96,691,000
Market Cap
$307.19 million
Optionable
Optionable
Beta
1.30
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ANNX) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners